UK markets closed

Bone Therapeutics SA (BNZPF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
4.20000.0000 (0.00%)
At close: 11:30AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.22
52-week change 3-1.41%
S&P500 52-week change 3-7.20%
52-week high 34.2600
52-week low 34.2000
50-day moving average 34.2000
200-day moving average 34.2298

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 57.83M
Implied shares outstanding 6N/A
Float 818.8M
% held by insiders 118.93%
% held by institutions 16.54%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021


Profit margin 0.00%
Operating margin (ttm)-601.06%

Management effectiveness

Return on assets (ttm)-35.10%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)2.08M
Revenue per share (ttm)0.12
Quarterly revenue growth (yoy)-6.70%
Gross profit (ttm)2.75M
EBITDA -12.28M
Net income avi to common (ttm)-12.93M
Diluted EPS (ttm)-0.8060
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.51M
Total cash per share (mrq)0.45
Total debt (mrq)20.91M
Total debt/equity (mrq)N/A
Current ratio (mrq)2.14
Book value per share (mrq)-0.32

Cash flow statement

Operating cash flow (ttm)-12.78M
Levered free cash flow (ttm)-10.21M